Skip to content
value.today

Tenaya Therapeutics, Inc.: insider trading

128 trades by 16 directors, officers and 10% owners since 2021, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$6.0 M
34 sales by 5 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$2 K
2 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$25.0 M-$5.9 M$0Feb 2024: bought $10.0 M (2 trades), sold $168 K (6 trades)Feb 24Mar 2024: bought $0 (0 trades), sold $23 K (1 trades)Aug 2024: bought $0 (0 trades), sold $56 K (7 trades)AugNov 2024: bought $0 (0 trades), sold $5 K (1 trades)Mar 2025: bought $25.0 M (2 trades), sold $11 K (8 trades)MarMay 2025: bought $0 (0 trades), sold $3 K (3 trades)Aug 2025: bought $0 (0 trades), sold $28 K (9 trades)AugNov 2025: bought $0 (0 trades), sold $10 K (3 trades)Feb 2026: bought $0 (0 trades), sold $5.9 M (21 trades)FebMay 2026: bought $0 (0 trades), sold $6 K (3 trades)Aug 2026: bought $0 (0 trades), sold $21 K (8 trades)AugNov 2026: bought $0 (0 trades), sold $2 K (2 trades)
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (16)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Tenaya Therapeutics, Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Faraz AliChief Executive Officer, Director536,283—$29 K
Whittemore TingleyChief Medical Officer259,850—$12 K
Tomohiro HigaSVP, Finance118,267—$3 K
TCG Opportunity III GP, LLC10% owner——$2.4 M
Column Group Iii-A, LP10% owner——$3.5 M
Column Group III, LP10% owner———
David V. GoeddelDirector, 10% owner———
Chihiro SaitoSVP, Accounting and Fin. Ops.60,983——
Timothy HoeyChief Scientific Officer245,346——
Leone D. PattersonChief Fin. and Bus. Officer95,755——
Column Group III GP, LP10% owner———
Deepak SrivastavaDirector———
Casdin Capital, LLCDirector———
Casdin Private Growth Equity Fund, L.P.10% owner———
Eli CasdinDirector, 10% owner———
JeenJoo KangDirector25,000——

Trades#

Tenaya Therapeutics, Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Faraz AliChief Executive Officer, DirectorSell-3,499$0.321$1 K536,283Form 4
filed Whittemore TingleyChief Medical OfficerSell-3,223$0.321$1 K259,850Form 4
filed Whittemore TingleyChief Medical OfficerGrant or award+49,000——263,073Form 4
filed Faraz AliChief Executive Officer, DirectorGrant or award+122,000——539,782Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,637$0.710$1 K219,860Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,837$0.710$4 K434,177Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,969$0.710$3 K430,208Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,637$0.710$1 K218,223Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,871$0.710$1 K216,352Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,020$0.710$4 K425,188Form 4
filed Whittemore TingleyChief Medical OfficerSell-2,279$0.710$2 K214,073Form 4
filed Faraz AliChief Executive Officer, DirectorSell-7,406$0.710$5 K417,782Form 4
filed Whittemore TingleyChief Medical OfficerSell-3,121$0.790$2 K215,497Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,390$0.790$3 K440,014Form 4
filed Tomohiro HigaSVP, FinanceSell-1,485$0.790$1 K118,267Form 4
filed TCG Opportunity III GP, LLC10% ownerSellindirect-1.65 M$0.560$924 K0Form 4
filed TCG Opportunity III GP, LLC10% ownerSellindirect-1.86 M$0.560$1.0 M0Form 4
filed TCG Opportunity III GP, LLC10% ownerSellindirect-309,228$0.620$192 K1.65 MForm 4
filed TCG Opportunity III GP, LLC10% ownerSellindirect-349,212$0.620$217 K1.86 MForm 4
filed Column Group Iii-A, LP10% ownerSellindirect-143,709$0.600$86 K1.96 MForm 4
filed Column Group Iii-A, LP10% ownerSellindirect-162,291$0.600$97 K2.21 MForm 4
filed Column Group Iii-A, LP10% ownerSellindirect-245,965$0.610$150 K2.10 MForm 4
filed Column Group Iii-A, LP10% ownerSellindirect-277,769$0.610$169 K2.37 MForm 4
filed Whittemore TingleyChief Medical OfficerSell-1,642$0.640$1 K222,136Form 4
filed Tomohiro HigaSVP, FinanceSell-611$0.640$391122,610Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,851$0.640$4 K452,415Form 4
filed Tomohiro HigaSVP, FinanceSell-836$0.640$535121,774Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,979$0.640$3 K448,436Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,642$0.640$1 K220,494Form 4
filed Tomohiro HigaSVP, FinanceSell-2,022$0.640$1 K119,752Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,876$0.640$1 K218,618Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,032$0.640$3 K443,404Form 4
filed Column Group Iii-A, LP10% ownerSellindirect-1.91 M$0.680$1.3 M2.35 MForm 4
filed Column Group Iii-A, LP10% ownerSellindirect-2.15 M$0.680$1.5 M2.65 MForm 4
filed Column Group Iii-A, LP10% ownerSellindirect-161,422$0.820$132 K4.25 MForm 4
filed Column Group Iii-A, LP10% ownerSellindirect-182,295$0.820$149 K4.80 MForm 4
filed Whittemore TingleyChief Medical OfficerGrant or award+48,750——223,778Form 4
filed Tomohiro HigaSVP, FinanceGrant or award+29,250——123,221Form 4
filed Faraz AliChief Executive Officer, DirectorGrant or award+158,600——458,266Form 4
filed Tomohiro HigaSVP, FinanceSell-1,367$1.330$2 K93,971Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,126$1.330$4 K299,666Form 4
filed Whittemore TingleyChief Medical OfficerSell-2,877$1.330$4 K169,926Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,720$1.250$7 K311,605Form 4
filed Tomohiro HigaSVP, FinanceSell-523$1.250$65497,777Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,608$1.250$2 K176,248Form 4
filed Tomohiro HigaSVP, FinanceSell-717$1.250$89697,060Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,893$1.250$5 K307,712Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,608$1.250$2 K174,640Form 4
filed Tomohiro HigaSVP, FinanceSell-1,722$1.250$2 K95,338Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,837$1.250$2 K172,803Form 4
filed Faraz AliChief Executive Officer, DirectorSell-4,920$1.250$6 K302,792Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,189$0.440$1 K317,325Form 4
filed Tomohiro HigaSVP, FinanceSell-1,390$0.440$61298,300Form 4
filed Whittemore TingleyChief Medical OfficerSell-2,937$0.440$1 K171,856Form 4
filed Tomohiro HigaSVP, FinanceSell-1,017$0.540$549101,155Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,727$0.540$933180,464Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,794$0.540$3 K324,461Form 4
filed Tomohiro HigaSVP, FinanceSell-620$0.540$335100,535Form 4
filed Whittemore TingleyChief Medical OfficerSell-4,073$0.540$2 K176,391Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,947$0.540$2 K320,514Form 4
filed Tomohiro HigaSVP, FinanceSell-845$0.540$45699,690Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,598$0.540$863174,793Form 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+35.71 M$0.700$25.0 M49.31 MForm 4
filed Column Group III, LP10% ownerBuyindirect+35.71 M$0.700—49.31 MForm 4
filed Faraz AliChief Executive Officer, DirectorGrant or award+107,500——295,831Form 4
filed Faraz AliChief Executive Officer, DirectorGrant or award+34,424——330,255Form 4
filed Whittemore TingleyChief Medical OfficerGrant or award+40,000——147,106Form 4
filed Whittemore TingleyChief Medical OfficerGrant or award+31,676——178,782Form 4
filed Chihiro SaitoSVP, Accounting and Fin. Ops.Sell-2,258$2.120$5 K60,983Form 4
filed Chihiro SaitoSVP, Accounting and Fin. Ops.Sell-902$2.890$3 K64,702Form 4
filed Chihiro SaitoSVP, Accounting and Fin. Ops.Sell-654$2.890$2 K64,048Form 4
filed Chihiro SaitoSVP, Accounting and Fin. Ops.Sell-807$2.890$2 K63,241Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,802$2.890$17 K192,277Form 4
filed Whittemore TingleyChief Medical OfficerSell-5,803$2.890$17 K108,731Form 4
filed Faraz AliChief Executive Officer, DirectorSell-3,946$2.890$11 K188,331Form 4
filed Whittemore TingleyChief Medical OfficerSell-1,625$2.890$5 K107,106Form 4
filed Chihiro SaitoSVP, Accounting and Fin. Ops.Grant or award+25,000——65,604Form 4
filed Timothy HoeyChief Scientific OfficerSell10b5-1 plan-3,300$7.000$23 K245,346Form 4
filed Whittemore TingleyChief Medical OfficerGrant or award+35,000——108,534Form 4
filed Faraz AliChief Executive Officer, DirectorGrant or award+85,000——198,079Form 4
filed Timothy HoeyChief Scientific OfficerGrant or award+12,500——248,646Form 4
filed Leone D. PattersonChief Fin. and Bus. OfficerGrant or award+35,000——95,755Form 4
filed Timothy HoeyChief Scientific OfficerSell10b5-1 plan-6,369$5.310$34 K236,346Form 4
filed Timothy HoeyChief Scientific OfficerSell10b5-1 plan-200$6.170$1 K236,146Form 4
filed Whittemore TingleyChief Medical OfficerSell-6,500$5.860$38 K73,534Form 4
filed Faraz AliChief Executive Officer, DirectorSell-6,358$5.860$37 K113,079Form 4
filed Timothy HoeyChief Scientific OfficerSell-4,681$5.860$27 K242,715Form 4
filed Leone D. PattersonChief Fin. and Bus. OfficerSell-5,201$5.860$30 K60,755Form 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+2.22 M$4.500$10.0 M13.60 MForm 4
filed Column Group Iii-A, LP10% ownerBuyindirect+2.22 M$4.500—13.60 MForm 4
filed Timothy HoeyChief Scientific OfficerSell10b5-1 plan-7,243$4.260$31 K247,396Form 4
filed Leone D. PattersonChief Fin. and Bus. OfficerSell-4,452$3.810$17 K64,542Form 4
filed Timothy HoeyChief Scientific OfficerSell-4,007$3.810$15 K254,639Form 4
filed Faraz AliChief Executive Officer, DirectorSell-5,563$3.810$21 K119,437Form 4
filed Whittemore TingleyChief Medical OfficerSell-5,563$3.810—76,437Form 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+6,779$2.600$18 K11.38 MForm 4
filed Column Group III, LP10% ownerBuyindirect+6,779$2.600—11.38 MForm 4
filed Whittemore TingleyChief Medical OfficerGrant or award+35,000——35,000Form 4
filed Timothy HoeyChief Scientific OfficerGrant or award+30,000——228,646Form 4
filed Faraz AliChief Executive Officer, DirectorGrant or award+125,000——125,000Form 4
filed Leone D. PattersonChief Fin. and Bus. OfficerGrant or award+30,000——32,000Form 4
filed Whittemore TingleyChief Medical OfficerGrant or award+45,000——80,000Form 4
filed Leone D. PattersonChief Fin. and Bus. OfficerGrant or award+35,000——67,000Form 4
filed Timothy HoeyChief Scientific OfficerGrant or award+30,000——258,646Form 4
filed Column Group Iii-A, LP10% ownerBuyindirect+1.50 M$2.600—11.37 MForm 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+1.50 M$2.600$3.9 M11.37 MForm 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+69,739$2.500$174 K9.87 MForm 4
filed Column Group III GP, LP10% ownerBuyindirect+69,739$2.500—9.87 MForm 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+135,688$2.520$342 K9.80 MForm 4
filed Column Group III GP, LP10% ownerBuyindirect+135,688$2.520—9.80 MForm 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+49,463$2.490$123 K9.66 MForm 4
filed Column Group III GP, LP10% ownerBuyindirect+49,463$2.490—9.66 MForm 4
filed Deepak SrivastavaDirectorBuyindirect+230,769$2.600$600 K372,435Form 4
filed David V. GoeddelDirector, 10% ownerBuyindirect+9.62 M$2.600$25.0 M9.62 MForm 4
filed Column Group III, LP10% ownerBuyindirect+9.62 M$2.600—9.62 MForm 4
filed Casdin Capital, LLCDirectorBuyindirect+2.49 M$2.600$6.5 M6.08 MForm 4
filed Timothy HoeyChief Scientific OfficerSell10b5-1 plan-1,353$10.13$14 K198,646Form 4
filed Column Group III, LP10% ownerConversionindirect+4.39 M——4.41 MForm 4
filed JeenJoo KangDirectorConversion+12,500——25,000Form 4
filed Casdin Private Growth Equity Fund, L.P.10% ownerConversionindirect+2.37 M——2.37 MForm 4
filed Eli CasdinDirector, 10% ownerConversionindirect+2.37 M——2.37 MForm 4
filed David V. GoeddelDirector, 10% ownerConversionindirect+4.39 M——4.41 MForm 4
filed David V. GoeddelDirector, 10% ownerConversionindirect+4.96 M——4.99 MForm 4
filed Eli CasdinDirector, 10% ownerBuyindirect+850,000$15.00$12.8 M3.22 MForm 4
filed Casdin Private Growth Equity Fund, L.P.10% ownerBuyindirect+850,000$15.00—3.22 MForm 4
filed Column Group III, LP10% ownerConversionindirect+4.96 M——4.99 MForm 4
filed Eli CasdinDirector, 10% ownerConversionindirect+361,969——361,969Form 4
filed Casdin Private Growth Equity Fund, L.P.10% ownerConversionindirect+361,969——361,969Form 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice